Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is currently available. Interim safety a...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Edward E., Frenck, Robert W., Falsey, Ann R., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J., Bailey, Ruth, Swanson, Kena A., Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R., Lyke, Kirsten E., Raabe, Vanessa, Dormitzer, Philip R., Jansen, Kathrin U., Şahin, Uğur, Gruber, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583697/
https://www.ncbi.nlm.nih.gov/pubmed/33053279
http://dx.doi.org/10.1056/NEJMoa2027906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583697/
https://www.ncbi.nlm.nih.gov/pubmed/33053279
http://dx.doi.org/10.1056/NEJMoa2027906

Ejemplares similares